Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota
- PMID: 29141969
- PMCID: PMC5682996
- DOI: 10.3945/an.117.016568
Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota
Abstract
Encouraging scientific research into the health effects of dietary bioactive resveratrol has been confounded by its rapid first-pass metabolism, which leads to low in vivo bioavailability. Preliminary studies have shown that resveratrol can modulate gut microbiota composition, undergo biotransformation to active metabolites via the intestinal microbiota, or affect gut barrier function. In rodents, resveratrol can modify the relative Bacteroidetes:Firmicutes ratio and reverse the gut microbial dysbiosis caused by a high-fat diet. By upregulating the expression of genes involved in maintaining tight junctions between intestinal cells, resveratrol contributes to gut barrier integrity. The composition of the gut microbiome and rapid metabolism of resveratrol determines the production of resveratrol metabolites, which are found at greater concentrations in humans after ingestion than their parent molecule and can have similar biological effects. Resveratrol may affect cardiovascular risk factors such as elevated blood cholesterol or trimethylamine N-oxide concentrations. Modulating the composition of the gut microbiota by resveratrol may affect central energy metabolism and modify concentrations of satiety hormones to produce antiobesity effects. Encouraging research from animal models could be tested in humans.
Keywords: cardiovascular disease; gut barrier integrity; inflammation; microbiome; obesity; resveratrol.
© 2017 American Society for Nutrition.
Conflict of interest statement
Author disclosures: JKB, DR, PW, and RES are employees of DSM Nutritional Products, a supplier of nutritional ingredients, including resveratrol, for use in food, dietary supplements, pharmaceutic applications, and animal feed.
Figures

Similar articles
-
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats.J Nutr Biochem. 2015 Jun;26(6):651-60. doi: 10.1016/j.jnutbio.2015.01.002. Epub 2015 Feb 26. J Nutr Biochem. 2015. PMID: 25762527
-
A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.Food Funct. 2017 Dec 13;8(12):4644-4656. doi: 10.1039/c7fo01383c. Food Funct. 2017. PMID: 29152632
-
Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity.Food Funct. 2014 Jun;5(6):1241-9. doi: 10.1039/c3fo60630a. Epub 2014 Apr 11. Food Funct. 2014. PMID: 24722352
-
Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene.Biofactors. 2018 Jan;44(1):50-60. doi: 10.1002/biof.1409. Epub 2018 Jan 5. Biofactors. 2018. PMID: 29315906 Review.
-
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk.Curr Opin Clin Nutr Metab Care. 2015 Sep;18(5):515-20. doi: 10.1097/MCO.0000000000000209. Curr Opin Clin Nutr Metab Care. 2015. PMID: 26154278 Free PMC article. Review.
Cited by
-
Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease.Nutrients. 2021 Feb 22;13(2):699. doi: 10.3390/nu13020699. Nutrients. 2021. PMID: 33671569 Free PMC article. Review.
-
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease.Acta Pharm Sin B. 2020 Jan;10(1):3-18. doi: 10.1016/j.apsb.2019.11.017. Epub 2019 Dec 10. Acta Pharm Sin B. 2020. PMID: 31993304 Free PMC article. Review.
-
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.Acta Pharm Sin B. 2023 Jun 5;13(9):3598-637. doi: 10.1016/j.apsb.2023.06.001. Online ahead of print. Acta Pharm Sin B. 2023. PMID: 37360014 Free PMC article. Review.
-
The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis.Front Genet. 2020 Apr 7;11:297. doi: 10.3389/fgene.2020.00297. eCollection 2020. Front Genet. 2020. PMID: 32318095 Free PMC article. Review.
-
Evaluation of the Feasibility of In Vitro Metabolic Interruption of Trimethylamine with Resveratrol Butyrate Esters and Its Purified Monomers.Molecules. 2024 Jan 16;29(2):429. doi: 10.3390/molecules29020429. Molecules. 2024. PMID: 38257342 Free PMC article.
References
-
- Rothwell JA, Perez-Jimenez J, Neveu V, Medina-Remón A, M'Hiri N, García-Lobato P, Manach C, Knox C, Eisner R, Wishart DS, et al. Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database (Oxford) 2013;2013:bat070. - PMC - PubMed
-
- Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191–6. - PubMed
-
- Poulsen MM, Jorgensen JO, Jessen N, Richelsen B, Pedersen SB. Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci 2013;1290:74–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources